Compare PLATZ Co., Ltd. with Similar Stocks
Dashboard
1
Poor long term growth as Operating profit has grown by an annual rate -27.19% of over the last 5 years
2
With a growth in Net Profit of 80.2%, the company declared Very Positive results in Mar 26
3
With ROE of 5.70%, it has a fair valuation with a 0.94 Price to Book Value
4
Underperformed the market in the last 1 year
Stock DNA
Pharmaceuticals & Biotechnology
JPY 3,350 Million (Micro Cap)
17.00
NA
0.00%
0.15
7.13%
0.99
Revenue and Profits:
Net Sales:
2,287 Million
(Quarterly Results - Mar 2026)
Net Profit:
146 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
19.82%
0%
19.82%
6 Months
15.59%
0%
15.59%
1 Year
29.64%
0%
29.64%
2 Years
12.57%
0%
12.57%
3 Years
30.9%
0%
30.9%
4 Years
12.57%
0%
12.57%
5 Years
-44.37%
0%
-44.37%
PLATZ Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
5.52%
EBIT Growth (5y)
-27.19%
EBIT to Interest (avg)
20.26
Debt to EBITDA (avg)
1.59
Net Debt to Equity (avg)
0.20
Sales to Capital Employed (avg)
1.42
Tax Ratio
69.09%
Dividend Payout Ratio
32.90%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
7.26%
ROE (avg)
9.99%
Valuation key factors
Factor
Value
P/E Ratio
17
Industry P/E
Price to Book Value
0.94
EV to EBIT
23.58
EV to EBITDA
12.09
EV to Capital Employed
0.95
EV to Sales
0.44
PEG Ratio
0.15
Dividend Yield
NA
ROCE (Latest)
4.04%
ROE (Latest)
5.70%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
Bearish
Bearish
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
No Trend
Mildly Bullish
OBV
Mildly Bearish
Mildly Bullish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ
Mar'26
Dec'25
Change(%)
Net Sales
2,287.00
2,135.10
7.11%
Operating Profit (PBDIT) excl Other Income
183.60
114.20
60.77%
Interest
7.00
6.60
6.06%
Exceptional Items
0.00
0.00
Consolidate Net Profit
146.30
81.20
80.17%
Operating Profit Margin (Excl OI)
62.10%
35.80%
2.63%
USD in Million.
Net Sales
QoQ Growth in quarter ended Mar 2026 is 7.11% vs 13.66% in Dec 2025
Consolidated Net Profit
QoQ Growth in quarter ended Mar 2026 is 80.17% vs 812.28% in Dec 2025
Annual Results Snapshot (Consolidated) - Jun'25
Jun'25
Jun'24
Change(%)
Net Sales
8,422.70
6,387.50
31.86%
Operating Profit (PBDIT) excl Other Income
323.50
106.30
204.33%
Interest
18.90
11.00
71.82%
Exceptional Items
0.00
7.50
-100.00%
Consolidate Net Profit
193.00
65.70
193.76%
Operating Profit Margin (Excl OI)
21.80%
5.90%
1.59%
USD in Million.
Net Sales
YoY Growth in year ended Jun 2025 is 31.86% vs 1.19% in Jun 2024
Consolidated Net Profit
YoY Growth in year ended Jun 2025 is 193.76% vs -70.46% in Jun 2024
About PLATZ Co., Ltd. 
PLATZ Co., Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






